PROCEPT BioRobotics（纳斯达克股票代码：PRCT）报告第四季度每股亏损$(0.35)，低于分析师普遍预期的$(0.33)，低于6.06%。这一数据较去年同期每股亏损$(0.54)增长了35.19%。公司报告季度销售额为$68.2百万，高于分析师普遍预期的$66.78百万，上涨了2.13%。这一数据较去年同期的销售额$43.581百万增长了56.49%。

以上内容来自Benzinga Earnings专栏，原文如下：

PROCEPT BioRobotics (NASDAQ:PRCT) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.33) by 6.06 percent. This is a 35.19 percent increase over losses of $(0.54) per share from the same period last year. The company reported quarterly sales of $68.200 million which beat the analyst consensus estimate of $66.780 million by 2.13 percent. This is a 56.49 percent increase over sales of $43.581 million the same period last year.